Nav: ₹ 16.745 ↓ -2.27%
[as on 26 September, 2025]
Nav chart with SMA (Simple moving average) overlay
SMA (Simple Moving Average)
Returns
| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|
| HDFC Pharma and Healthcare Fund - Growth Option | -2% | -2.27% | -5.13% | -2.93% | 0.89% | 4.47% | - | - | - | - |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Cash & Equivalents |
|---|
| 98.89% |
1.11% (Arbitrage: 0.00%) |
0.00% |
0.00% |
Equity
| Name | Sector | Weight % |
|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals & Biotechnology | 10.39% |
| Divis Laboratories Ltd. | Pharmaceuticals & Biotechnology | 8.30% |
| Glenmark Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | 6.78% |
| Lupin Ltd. | Pharmaceuticals & Biotechnology | 6.73% |
| Cipla Ltd. | Pharmaceuticals & Biotechnology | 6.56% |
| Ipca Laboratories Ltd. | Pharmaceuticals & Biotechnology | 4.62% |
| Alkem Laboratories Ltd. | Pharmaceuticals & Biotechnology | 3.94% |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | 3.74% |
| Krishna Institute Of Medical Sciences Limited | Healthcare Services | 3.73% |
| Laurus Labs Ltd. | Pharmaceuticals & Biotechnology | 3.62% |
| Eris Lifesciences Ltd | Pharmaceuticals & Biotechnology | 3.60% |
| Anthem Biosciences Limited | Pharmaceuticals & Biotechnology | 3.47% |
| Aster DM Healthcare Limited | Healthcare Services | 3.38% |
| Max Healthcare Institute Limited | Healthcare Services | 3.26% |
| Metropolis Healthcare Ltd. | Healthcare Services | 2.82% |
| Vijaya Diagnostic Centre Limited | Healthcare Services | 2.45% |
| Acutaas Chemicals Limited | Pharmaceuticals & Biotechnology | 2.44% |
| Gland Pharma Ltd. | Pharmaceuticals & Biotechnology | 2.28% |
| Dr. Lal Path Labs Ltd | Healthcare Services | 2.04% |
| Cohance Lifesciences Limited | Pharmaceuticals & Biotechnology | 1.98% |
| Wockhardt Ltd. | Pharmaceuticals & Biotechnology | 1.93% |
| Fortis Healthcare Limited | Healthcare Services | 1.87% |
| Jubilant Pharmova Limited | Pharmaceuticals & Biotechnology | 1.70% |
| Piramal Pharma Limited | Pharmaceuticals & Biotechnology | 1.69% |
| Sai Life Sciences Limited | Pharmaceuticals & Biotechnology | 1.59% |
| Pfizer Ltd. | Pharmaceuticals & Biotechnology | 1.31% |
| BAJAJ HEALTHCARE LIMITED | Pharmaceuticals & Biotechnology | 1.16% |
| Laxmi Dental Limited | Healthcare Equipment & Supplies | 1.15% |
| Medi Assist Healthcare Services Limited | Insurance | 0.36% |
Debt
| Name | Rating | Weight % |
|---|
| TREPS - Tri-party Repo | | 1.03% |
| Net Current Assets | | 0.08% |
Portfolio data is as on date 31 August, 2025
FAQ (Frequently asked questions)
What is latest/current NAV/price of HDFC Pharma and Healthcare Fund - Growth Option?
The latest NAV of HDFC Pharma and Healthcare Fund - Growth Option is 16.745 as on 26 September, 2025.
What are YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option?
The YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option are -2% as on 26 September, 2025.
What are 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option?
The 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option are 4.47% as on 26 September, 2025.
